JPMorgan has added new names to its list of top stock picks for February, including a health technology company that surged earlier in the year. The S&P 500 had its best January in four years, up 6.2%. The Nasdaq Composite also had its strongest month since July, up 10.7%. The Dow Jones Industrial Average was up 2.8% last month. Investors started the year on a hopeful note, as slowing inflation figures helped fuel the recovery and fueled speculation that the Federal Reserve might begin to rein in war his tightening translation. The central bank raised interest rates by 0.25 percentage points on Wednesday and signaled that it will continue to raise rates. In February, JPMorgan added five new names to its focus list: Cenovus Energy, CMS Energy, Rogers Communications, Stryker and Treace Medical Concepts Stryker started 2023 successfully. Health tech shares are up 12% year-to-date. Analyst Robert Marcus highlighted the company’s “strong organic sales growth performance with growth potential, improved operating margins, and a healthy innovation rhythm.” JPMorgan said the new additions CMS Energy and Cenovus Energy are uniquely positioned in the industry, according to the note. Analyst John Royall wrote, referring to the price difference between West Texas Intermediate and Western Canada Select crude. “CVE is one of the very few companies in our coverage that is returning more capital to shareholders next year than it did this year,” he added. Shares of Cenovus are up 27% over the past 12 months. Names returning to the list include fast food giant McDonald’s and tech giant Amazon. Amazon’s stock has fallen more than 30% over the past 12 months, but it’s rebounded at the start of the year, up more than 24% in 2023. The company recently announced a wave of layoffs in January and is looking to move on. is set to release earnings on Thursday. McDonald’s reported quarterly results on Tuesday, beating analysts’ estimates. However, the company’s shares closed down more than 1% after CEO Chris Kempczinski offered a cautious outlook for 2023. tempered investor enthusiasm. The bank has removed the following companies from its focus list: AtriCure, Boston Scientific and Regions Financial. —CNBC Michael Bloom contributed to this story.